Spermatocytic seminoma: Toward further understanding of pathogenesis

Journal of Pathology

Volumn 224, Issue 4, 2011, Pages 431-433

  Looijenga, Leendert H J ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

expression profiling; germ cell tumours; histogenesis; OCT2; SAGE1; spermatocytic seminoma; SSX 2 4

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; OCTAMER TRANSCRIPTION FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; SAGE1 PROTEIN; SSX2 PROTEIN; SSX3 PROTEIN; SSX4 PROTEIN; STEM CELL FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

CELL MATURATION; GENE MUTATION; GERM CELL; GERM CELL TUMOR; HUMAN; ONCOGENE H RAS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEMINOMA; SPERMATOCYTIC SEMINOMA; SPERMATOGENESIS; SPERMATOGONIUM;

ANTIGENS, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; MALE; NEOPLASM PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; REPRESSOR PROTEINS; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959926433     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2939     Document Type: Review

References (13)

1. Lim J, Goriely A, Turner G, et al., OCT2, SSX and SAGE1 reveal the phenotypic hetereogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol 2011; 224: 473-483.
2. Burke AP, Mostofi FK,. Spermatocytic seminoma. A clinicopathologic study of 79 cases. J Urol Pathol 1993; 1: 21-32.
3. Oosterhuis J, Looijenga L,. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5: 210-222. (Pubitemid 40314952)
4. Rajpert-De Meyts E,. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12: 303-323.
5. Looijenga LH,. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 2009; 218: 146-162.
6. Looijenga LH, Stoop H, Hersmus R, et al., Genomic and expression profiling of human spermatocytic seminomas: pathogenetic implications. Int J Androl 2007; 30: 328-335; discussion, 335-326. (Pubitemid 47254422)
7. Stoop H, Van Gurp R, De Krijger R, et al., Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest 2001; 81: 919-928. (Pubitemid 32645966)
8. Rajpert-De Meyts E, Jacobsen GK, Bartkova J, et al., The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 2003; 42: 217-226. (Pubitemid 36356853)
9. Goriely A, Hansen RM, Taylor IB, et al., Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 2009; 41: 1247-1252.
10. Bergner DM, Duck GB, Rao M,. Bilateral sequential spermatocytic seminoma. J Urol 1980; 124: 565. (Pubitemid 10030204)
11. Looijenga LHJ, Olie RA, Van der Gaag I, et al., Seminomas of the canine testis; counterpart of spermatocytic seminoma of men? Lab Invest 1994; 71: 490-496. (Pubitemid 24338156)
12. Maiolino P, Restucci B, Papparella S, et al., Correlation of nuclear morphometric features with animal and human World Health Organization international histological classifications of canine spontaneous seminomas. Vet Pathol 2004; 41: 608-611. (Pubitemid 39573751)
13. Looijenga LHJ, Oosterhuis JW,. Are all testicular seminomas of animals in fact spermatocytic seminomas? Towards a comprehensive investigation. Vet Pathol 2007; 44: 126.